• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Vasc Pharmacol . QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study

tetano

Editor, Senior Moderator
Curr Vasc Pharmacol


. 2023 Dec 8.
doi: 10.2174/0115701611250248231114114557. Online ahead of print. QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study

Andrea Sartorio[SUP] 1 [/SUP], Giulia Burrei[SUP] 1 [/SUP], Luca Cristin[SUP] 1 [/SUP], Mirko Zoncapè[SUP] 1 [/SUP], Michele Carlin[SUP] 1 [/SUP], Enrico Tadiello[SUP] 1 [/SUP], Pietro Minuz[SUP] 1 [/SUP], Andrea Dalbeni[SUP] 1 [/SUP], Simone Romano[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes Coronavirus disease 2019 (COVID-19), characterized by pulmonary infection ranging from asymptomatic forms to respiratory insufficiency and death. Evidence of cardiac involvement in COVID-19 is increasing, and systemic inflammation or direct heart damage by SARS-CoV-2 can prolong the corrected QT interval (QTc).
Methods: In this observational study, a total of 333 consecutive patients admitted to the Covid Center of Verona University Hospital from November 2020 to April 2021 were included. Patients with bundle branch block, pacemaker-controlled heart rhythm and heart rate >120 beats/min were excluded. A complete electrocardiogram (ECG) was performed at admission, and QTc values of ≥440 ms for males and ≥460 ms for females were considered prolonged.
Results: Overall, 153 patients had prolonged QTc (45.5%). In multivariate logistic regression analysis, male sex (odds ratio (OR)=6.612, p=0.046), troponin (OR=1.04, p=0.015) and lymphocyte count (OR=3.047, p=0.019) were independently associated with QTc prolongation. Multivariate logistic regression showed that QTc was independently associated with mortality (OR=4.598, p=0.036). Age, sex, the ratio between the partial pressure of oxygen (PaO2) and the fraction of inspired oxygen (FiO2) (P/F), and fibrosis-4 index for liver fibrosis (FIB-4) were also independently associated with mortality.
Conclusion: QTc interval prolongation appears to be a frequent finding in patients with COVID-19. Moreover, prolonged QTc may be predictive of more severe forms of COVID-19 and worse outcome.

Keywords: COVID-19; COVID-19 drugs; QTc prolongation; SARS-CoV-2; mortality; pneumonia.

 
Back
Top Bottom